Status:
COMPLETED
The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hematological Malignancies
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine: * Condition of intensive care unit (ICU) admission in patients with haematological malignancies. * ICU hospital and up to one year mortality. * Assessment o...
Detailed Description
1. To identify prognostic factors of short and medium term mortality, by underlining the respective weights of organ dysfunction and characteristics of underlined malignancy 2. Evaluate the health rel...
Eligibility Criteria
Inclusion
- Hematological malignancies
- hospitalization in ICU
- age \>= 18 years
Exclusion
- Patients who have already participated to TRIAL-OH
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
1011 Patients enrolled
Trial Details
Trial ID
NCT01172132
Start Date
November 1 2009
End Date
November 1 2011
Last Update
April 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint-Louis, AP-HP
Paris, France, 75475